Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
2023 · Annals of Oncology · 36 citations
https://doi.org/10.1016/j.annonc.2023.11.013
L
L. Del Carpio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
46
Citations
2
h-index
1
i10-index
L. Del Carpio is an academic researcher from Parc Sanitari Sant Joan de Déu. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Prostate Cancer Treatment and Research & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 2, co-authored 6 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat